ArticleWorld journal of gastroenterology2022

Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.

Flavia Maria Silva-Veiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.